25Nov 2023
Surgical versus medical castration in the treatment of metastatic prostate cancer

Surgical versus medical castration in the treatment of metastatic prostate cancer

The study compared the efficacy, side effects, and cost-effectiveness of surgical castration and medical castration using long-acting gonadotropin-releasing hormone (GnRH) analogues in metastatic prostate cancer patients. The meta-analysis of 15 studies with 63,682 participants revealed a trend towards superior overall survival with surgical castration and potentially lower cardiovascular complications. However, medical castration showed a significantly lower nadir prostate-specific antigen (PSA) level. The findings suggest that surgical castration may be a safe and effective alternative, potentially offering survival benefits and limited financial advantages. Further research is needed to refine cost considerations and identify optimal treatment for specific patient subgroups.

  • #urology

Like

Save

Share